Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Chief Acc Officer, Treasurer | May 24, 2021 | May 24, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date May 24, 2021 · Filed May 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,646 |
Reported balance
After 2021-05-24 transaction · row 1
1 source rowRow 1 · 2021-05-24 · Sale · Disposed 854 · Balance 36,646 F1: The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units. F2: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $47.12 to $48.65. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F2: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $47.12 to $48.65. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2021 Filed May 24, 2021 23:43 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 854 | $48.65 | $41,545.39 |
DisclosureSEC source: 0001209191-21-035531 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,646 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $47.12 to $48.65. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 05, 2021 Filed May 6, 2021 21:44 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 10,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030680 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 5, 2022 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| May 05, 2021 Filed May 10, 2021 22:32 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 10,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031398 · doc4a.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 15, 2022, with the remaining RSUs vesting in 3 equal annual installments thereafter. The prior Form 4 incorrectly reported that 25% of the RSUs vest and become exercisable on May 5, 2022, with the remaining RSUs vesting in 3 equal annual installments thereafter. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 00:35 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 668 | $42.00 | $28,056.00 |
DisclosureSEC source: 0001209191-21-011521 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,630 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:32 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,018 | $30.10 | $30,641.80 |
DisclosureSEC source: 0001209191-20-061672 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,298 Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 21:31 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,641 | $44.80 | $73,518.93 |
DisclosureSEC source: 0001209191-20-048553 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,316 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and July 2019. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.80 to $45.16. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2020 Filed Jun 4, 2020 23:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,197 | $54.32 | $65,018.05 |
DisclosureSEC source: 0001209191-20-034563 · doc4.xml · nonDerivative · entry 2 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,957 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units and restricted stock units (the "Bonus RSUs") received in lieu of a cash bonus payment the Recipient was eligible to receive pursuant to the Issuer's Short-Term Incentive Plan for services performed by the Recipient during the fiscal year ended March 31, 2020. The Issuer's Compensation Committee issued the Bonus RSUs in lieu of the cash bonus payment to help conserve the Issuer's cash resources. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $54.00 to $54.90. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 23:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 604 | $52.76 | $31,869.34 |
DisclosureSEC source: 0001209191-20-034563 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,154 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units and restricted stock units (the "Bonus RSUs") received in lieu of a cash bonus payment the Recipient was eligible to receive pursuant to the Issuer's Short-Term Incentive Plan for services performed by the Recipient during the fiscal year ended March 31, 2020. The Issuer's Compensation Committee issued the Bonus RSUs in lieu of the cash bonus payment to help conserve the Issuer's cash resources. Read SEC document |
| May 26, 2020 Filed May 28, 2020 22:19 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 1,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032704 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,758 F1 · shares: Represents the issuance of restricted stock units (the "RSUs") in lieu of a cash bonus payment the Recipient was eligible to receive pursuant to the Issuer's Short-Term Incentive Plan for services performed by the Recipient during the fiscal year ended March 31, 2020. The Issuer's Compensation Committee issued the RSUs in lieu of the cash bonus payment to help conserve the Issuer's cash resources. Read SEC document |
| May 06, 2020 Filed May 7, 2020 22:00 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 9,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027769 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,957 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 15, 2021 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:49 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 492 | $49.43 | $24,319.56 |
DisclosureSEC source: 0001209191-20-012671 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,335 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted February 2019. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 23:24 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 517 | $40.31 | $20,840.27 |
DisclosureSEC source: 0001209191-19-060976 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,827 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted December 2015. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 21:32 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 732 | $41.99 | $30,736.68 |
DisclosureSEC source: 0001209191-19-046840 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,344 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018. Read SEC document |
| July 30, 2019 Filed Aug 5, 2019 22:16 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-044674 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,076 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on August 15, 2020 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.